Anti-cancer drug kills 124 in Japan

Side effects from the cancer-fighting drug Gefitinib have resulted in 124 deaths in Japan, a government official said today.

The dead were among 494 patients who have developed debilitating lung disorders, including pneumonia, blamed on the drug, according to Toshihito Ikeda of the Health and Welfare Ministry.